Phase II, Parallel, Randomized, Clinical Trial Comparing the Responses to Initiation of NNRTI -Based Versus PI -Based Antiretroviral Therapy in HIV Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mother-to-Child HIV Transmission.

Trial Profile

Phase II, Parallel, Randomized, Clinical Trial Comparing the Responses to Initiation of NNRTI -Based Versus PI -Based Antiretroviral Therapy in HIV Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mother-to-Child HIV Transmission.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Nevirapine (Primary) ; Lamivudine; Lopinavir/ritonavir; Zidovudine
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2017 Results (n=451) assessing long-term metabolic implications of lopinavir/ritonavir-based regimens for infants and children presented at the 9th International AIDS Society Conference on HIV Science
    • 10 Jun 2017 Biomarkers information updated
    • 19 Jan 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top